vs

Side-by-side financial comparison of PURE CYCLE CORP (PCYO) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.

PURE CYCLE CORP is the larger business by last-quarter revenue ($9.1M vs $5.5M, roughly 1.7× Taysha Gene Therapies, Inc.). PURE CYCLE CORP runs the higher net margin — 50.0% vs -507.8%, a 557.7% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 58.8%). Over the past eight quarters, PURE CYCLE CORP's revenue compounded faster (69.0% CAGR vs 26.8%).

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.

PCYO vs TSHA — Head-to-Head

Bigger by revenue
PCYO
PCYO
1.7× larger
PCYO
$9.1M
$5.5M
TSHA
Growing faster (revenue YoY)
TSHA
TSHA
+112.5% gap
TSHA
171.3%
58.8%
PCYO
Higher net margin
PCYO
PCYO
557.7% more per $
PCYO
50.0%
-507.8%
TSHA
Faster 2-yr revenue CAGR
PCYO
PCYO
Annualised
PCYO
69.0%
26.8%
TSHA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PCYO
PCYO
TSHA
TSHA
Revenue
$9.1M
$5.5M
Net Profit
$4.6M
$-27.9M
Gross Margin
68.4%
Operating Margin
48.0%
-516.0%
Net Margin
50.0%
-507.8%
Revenue YoY
58.8%
171.3%
Net Profit YoY
16.0%
-48.3%
EPS (diluted)
$0.19
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCYO
PCYO
TSHA
TSHA
Q4 25
$9.1M
$5.5M
Q3 25
$11.2M
$0
Q2 25
$5.1M
$2.0M
Q1 25
$4.0M
$2.3M
Q4 24
$5.8M
$2.0M
Q3 24
$12.6M
$1.8M
Q2 24
$7.6M
$1.1M
Q1 24
$3.2M
$3.4M
Net Profit
PCYO
PCYO
TSHA
TSHA
Q4 25
$4.6M
$-27.9M
Q3 25
$6.1M
$-32.7M
Q2 25
$2.3M
$-26.9M
Q1 25
$809.0K
$-21.5M
Q4 24
$3.9M
$-18.8M
Q3 24
$6.6M
$-25.5M
Q2 24
$2.8M
$-20.9M
Q1 24
$118.0K
$-24.1M
Gross Margin
PCYO
PCYO
TSHA
TSHA
Q4 25
68.4%
Q3 25
67.7%
Q2 25
63.4%
Q1 25
38.2%
Q4 24
63.8%
Q3 24
77.8%
Q2 24
64.0%
Q1 24
55.6%
Operating Margin
PCYO
PCYO
TSHA
TSHA
Q4 25
48.0%
-516.0%
Q3 25
53.1%
Q2 25
26.0%
-1347.1%
Q1 25
-33.2%
-930.5%
Q4 24
29.9%
-985.8%
Q3 24
62.0%
-1448.4%
Q2 24
40.3%
-1915.4%
Q1 24
-11.5%
-713.3%
Net Margin
PCYO
PCYO
TSHA
TSHA
Q4 25
50.0%
-507.8%
Q3 25
54.5%
Q2 25
43.9%
-1353.6%
Q1 25
20.3%
-935.2%
Q4 24
68.4%
-929.0%
Q3 24
52.6%
-1427.5%
Q2 24
37.2%
-1882.0%
Q1 24
3.7%
-705.4%
EPS (diluted)
PCYO
PCYO
TSHA
TSHA
Q4 25
$0.19
$-0.08
Q3 25
$0.26
$-0.09
Q2 25
$0.09
$-0.09
Q1 25
$0.03
$-0.08
Q4 24
$0.16
$-0.07
Q3 24
$0.27
$-0.10
Q2 24
$0.12
$-0.09
Q1 24
$0.00
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCYO
PCYO
TSHA
TSHA
Cash + ST InvestmentsLiquidity on hand
$17.1M
$319.8M
Total DebtLower is stronger
$8.0M
Stockholders' EquityBook value
$147.5M
$246.9M
Total Assets
$168.1M
$343.3M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCYO
PCYO
TSHA
TSHA
Q4 25
$17.1M
$319.8M
Q3 25
$21.9M
$297.3M
Q2 25
$14.4M
$312.8M
Q1 25
$16.5M
$116.6M
Q4 24
$19.0M
$139.0M
Q3 24
$22.1M
$157.7M
Q2 24
$20.5M
$172.7M
Q1 24
$20.6M
$124.0M
Total Debt
PCYO
PCYO
TSHA
TSHA
Q4 25
$8.0M
Q3 25
$6.8M
Q2 25
$6.9M
Q1 25
$6.9M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
Q1 24
Stockholders' Equity
PCYO
PCYO
TSHA
TSHA
Q4 25
$147.5M
$246.9M
Q3 25
$142.7M
$219.0M
Q2 25
$136.7M
$248.7M
Q1 25
$134.4M
$55.1M
Q4 24
$133.6M
$71.5M
Q3 24
$129.7M
$88.8M
Q2 24
$123.2M
$108.9M
Q1 24
$120.4M
$53.8M
Total Assets
PCYO
PCYO
TSHA
TSHA
Q4 25
$168.1M
$343.3M
Q3 25
$162.3M
$316.6M
Q2 25
$151.7M
$333.3M
Q1 25
$149.7M
$138.4M
Q4 24
$149.7M
$160.4M
Q3 24
$147.4M
$180.2M
Q2 24
$140.4M
$200.4M
Q1 24
$135.2M
$153.0M
Debt / Equity
PCYO
PCYO
TSHA
TSHA
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCYO
PCYO
TSHA
TSHA
Operating Cash FlowLast quarter
$-979.0K
$-26.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCYO
PCYO
TSHA
TSHA
Q4 25
$-979.0K
$-26.7M
Q3 25
$9.4M
$-24.2M
Q2 25
$-503.0K
$-20.2M
Q1 25
$-1.4M
$-22.0M
Q4 24
$5.7M
$-18.3M
Q3 24
$3.1M
$-21.6M
Q2 24
$892.0K
$-21.5M
Q1 24
$-457.0K
$-19.8M
Free Cash Flow
PCYO
PCYO
TSHA
TSHA
Q4 25
Q3 25
$-24.3M
Q2 25
Q1 25
Q4 24
$-18.3M
Q3 24
$-21.6M
Q2 24
$-21.7M
Q1 24
$-19.9M
FCF Margin
PCYO
PCYO
TSHA
TSHA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-905.5%
Q3 24
-1210.9%
Q2 24
-1951.9%
Q1 24
-584.5%
Capex Intensity
PCYO
PCYO
TSHA
TSHA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.1%
Q3 24
2.0%
Q2 24
18.1%
Q1 24
4.1%
Cash Conversion
PCYO
PCYO
TSHA
TSHA
Q4 25
-0.21×
Q3 25
1.53×
Q2 25
-0.22×
Q1 25
-1.70×
Q4 24
1.44×
Q3 24
0.47×
Q2 24
0.32×
Q1 24
-3.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

TSHA
TSHA

Segment breakdown not available.

Related Comparisons